Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy. | Cancers (Basel) | 2022 | 36497394 | PubTator, text mining | PubMed |
| An Update on the Metabolic Landscape of Oncogenic Viruses. | Cancers (Basel) | 2022 | 36497226 | PubTator, text mining | PubMed |
| Induced pluripotent stem cell-derived cells model brain microvascular endothelial cell glucose metabolism. | Fluids Barriers CNS | 2022 | 36494870 | PubTator, text mining | PubMed |
| Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism. | Front Oncol | 2022 | 36483029 | PubTator, text mining | PubMed |
| TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway. | BMC Cancer | 2022 | 36471278 | PubTator, text mining | PubMed |
| Investigations into photoreceptor energy metabolism during experimental retinal detachment. | Front Cell Neurosci | 2022 | 36467607 | PubTator, text mining | PubMed |
| Transcriptomic analysis identifies shared biological foundations between ischemic stroke and Alzheimer's disease. | Front Neurosci | 2022 | 36466169 | PubTator, text mining | PubMed |
| Proteomics profiles of blood glucose-related proteins involved in a Chinese longevity cohort. | Clin Proteomics | 2022 | 36463101 | PubTator, text mining | PubMed |
| Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs. | Front Endocrinol (Lausanne) | 2022 | 36457557 | PubTator, text mining | PubMed |
| Metabolic reprogramming of pulmonary fibrosis. | Front Pharmacol | 2022 | 36452229 | PubTator, text mining | PubMed |
| RNA Modifications Meet Tumors. | Cancer Manag Res | 2022 | 36444355 | PubTator, text mining | PubMed |
| Spike Protein Subunits of SARS-CoV-2 Alter Mitochondrial Metabolism in Human Pulmonary Microvascular Endothelial Cells: Involvement of Factor Xa. | Dis Markers | 2022 | 36438904 | PubTator, text mining | PubMed |
| Natural compounds targeting glycolysis as promising therapeutics for gastric cancer: A review. | Front Pharmacol | 2022 | 36438836 | PubTator, text mining | PubMed |
| A new strategy for osteoarthritis therapy: Inhibition of glycolysis. | Front Pharmacol | 2022 | 36438808 | PubTator, text mining | PubMed |
| Characterization of Mitochondrial Alterations in Aicardi-Goutières Patients Mutated in RNASEH2A and RNASEH2B Genes. | Int J Mol Sci | 2022 | 36430958 | PubTator, text mining | PubMed |
BDE-47, -99, -209 and Their Ternary Mixture Disrupt Glucose and Lipid Metabolism of Hepg2 Cells at Dietary Relevant Concentrations: Mechanistic Insight through Integrated Transcriptomics and Proteomics Analysis. | Int J Mol Sci | 2022 | 36430946 | PubTator, text mining | PubMed |
Cytotoxicity, Mitochondrial Functionality, and Redox Status of Human Conjunctival Cells after Short and Chronic Exposure to Preservative-Free Bimatoprost 0.03% and 0.01%: An In Vitro Comparative Study. | Int J Mol Sci | 2022 | 36430590 | PubTator, text mining | PubMed |
| Lactate Activates AMPK Remodeling of the Cellular Metabolic Profile and Promotes the Proliferation and Differentiation of C2C12 Myoblasts. | Int J Mol Sci | 2022 | 36430479 | PubTator, text mining | PubMed |
| MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome. | Int J Mol Sci | 2022 | 36430448 | PubTator, text mining | PubMed |
| Illuminating the Molecular Intricacies of Exosomes and ncRNAs in Cardiovascular Diseases: Prospective Therapeutic and Biomarker Potential. | Cells | 2022 | 36429092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=32